Evaluating overdose prevention programs in New York City and Rhode Island
A comparative evaluation of overdose prevention programs in New York City and Rhode Island
['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-11059052
This study is looking at how well overdose prevention centers in New York City and Rhode Island help people who use drugs by providing a safe place to use under medical supervision, and it aims to see how these centers affect health, community safety, and access to treatment for those who need it.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11059052 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness of overdose prevention centers (OPCs) in New York City and Rhode Island, which allow individuals to consume pre-obtained drugs under medical supervision. The study will assess the health and community benefits of these centers, including their impact on overdose rates and access to health services. By following a cohort of 500 individuals who use these centers, the research aims to gather data on safety, education, and referrals to treatment. The evaluation will also explore any unintended consequences of these programs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use or are at risk of using opioids and are seeking safer consumption options.
Not a fit: Patients who do not use drugs or are not at risk of overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing drug overdoses and enhancing community health services.
How similar studies have performed: Research from other countries has shown positive outcomes from similar overdose prevention programs, indicating potential success for this approach in the U.S.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CERDA, MAGDALENA — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: CERDA, MAGDALENA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus